FibroBiologics, Inc.'s market cap is currently $16.79M. The company's EPS TTM is $-0.12; its P/E ratio is ―; FibroBiologics, Inc. is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
